MCWS
ABBV icon

McKinley Carter Wealth Services’s AbbVie ABBV Stock Holding History

McKinley Carter Wealth Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.04M Sell
23,152
-890
-4% -$197K 0.29% 81
2025
Q4 		$5.49M Buy
24,042
+9
+0% +$2.05K 0.31% 74
2025
Q3 		$5.56M Sell
24,033
-69
-0.3% -$14.1K 0.29% 69
2025
Q2 		$4.47M Buy
24,102
+2,076
+9% +$386K 0.25% 75
2025
Q1 		$4.61M Buy
22,026
+776
+4% +$151K 0.28% 68
2024
Q4 		$3.78M Buy
21,250
+18
+0.1% +$3.31K 0.23% 77
2024
Q3 		$4.19M Buy
21,232
+148
+0.7% +$27.6K 0.25% 77
2024
Q2 		$3.62M Buy
21,084
+184
+0.9% +$30.5K 0.23% 80
2024
Q1 		$3.81M Buy
20,900
+376
+2% +$64.8K 0.25% 77
2023
Q4 		$3.18M Buy
20,524
+379
+2% +$55.3K 0.23% 81
2023
Q3 		$3M Sell
20,145
-337
-2% -$49.5K 0.24% 80
2023
Q2 		$2.76M Sell
20,482
-316
-2% -$46.3K 0.21% 86
2023
Q1 		$3.31M Buy
20,798
+110
+0.5% +$16.8K 0.26% 72
2022
Q4 		$3.34M Buy
20,688
+1,222
+6% +$187K 0.28% 74
2022
Q3 		$2.61M Sell
19,466
-744
-4% -$107K 0.24% 76
2022
Q2 		$3.1M Buy
20,210
+161
+0.8% +$24.6K 0.27% 70
2022
Q1 		$3.25M Buy
20,049
+1,095
+6% +$159K 0.25% 74
2021
Q4 		$2.57M Sell
18,954
-27
-0.1% -$3.19K 0.19% 90
2021
Q3 		$2.05M Buy
18,981
+555
+3% +$63.4K 0.17% 100
2021
Q2 		$2.08M Sell
18,426
-17
-0.1% -$1.92K 0.17% 98
2021
Q1 		$2M Buy
18,443
+1,975
+12% +$211K 0.17% 108
2020
Q4 		$1.76M Sell
16,468
-2,260
-12% -$217K 0.23% 93
2020
Q3 		$1.64M Buy
18,728
+386
+2% +$36.3K 0.37% 57
2020
Q2 		$1.8M Buy
18,342
+499
+3% +$43.9K 0.44% 48
2020
Q1 		$1.36M Buy
17,843
+1,451
+9% +$124K 0.41% 52
2019
Q4 		$1.45M Sell
16,392
-20
-0.1% -$1.66K 0.34% 67
2019
Q3 		$1.24M Buy
16,412
+2,841
+21% +$195K 0.32% 71
2019
Q2 		$987K Buy
13,571
+318
+2% +$25K 0.27% 73
2019
Q1 		$1.07M Buy
13,253
+1,442
+12% +$118K 0.3% 69
2018
Q4 		$1.09M Buy
11,811
+2,322
+24% +$204K 0.36% 65
2018
Q3 		$897K Buy
9,489
+147
+2% +$13.9K 0.27% 74
2018
Q2 		$866K Buy
9,342
+862
+10% +$84.2K 0.28% 71
2018
Q1 		$803K Buy
8,480
+1,641
+24% +$180K 0.26% 75
2017
Q4 		$661K Sell
6,839
-10
-0.1% -$942 0.23% 84
2017
Q3 		$609K Buy
6,849
+2,432
+55% +$185K 0.23% 80
2017
Q2 		$320K Buy
4,417
+296
+7% +$19.9K 0.14% 100
2017
Q1 		$269K Hold
4,121
– – 0.12% 107
2016
Q4 		$258K Hold
4,121
– – 0.13% 104
2016
Q3 		$260K Buy
4,121
+1
+0% +$65 0.13% 103
2016
Q2 		$255K Hold
4,120
– – 0.13% 107
2016
Q1 		$235K Buy
4,120
+94
+2% +$5.24K 0.13% 112
2015
Q4 		$239K Hold
4,026
– – 0.14% 99
2015
Q3 		$219K Sell
4,026
-941
-19% -$61.3K 0.14% 103
2015
Q2 		$334K Buy
4,967
+429
+9% +$28K 0.18% 98
2015
Q1 		$266K Buy
4,538
+853
+23% +$51.5K 0.17% 95
2014
Q4 		$241K Sell
3,685
-188
-5% -$11.9K 0.19% 88
2014
Q3 		$224K Sell
3,873
-912
-19% -$50.6K 0.21% 86
2014
Q2 		$270K Buy
+4,785
New +$251K 0.28% 71
2014
Q1 		– Sell
-6,796
Closed -$359K – 94
2013
Q4 		$359K Sell
6,796
-574
-8% -$28.2K 0.35% 76
2013
Q3 		$330K Buy
7,370
+1,106
+18% +$49K 0.39% 58
2013
Q2 		$259K Buy
+6,264
New +$274K 0.39% 52

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

McKinley Carter Wealth Services's ABBV Position: Q1 2026 in Review

McKinley Carter Wealth Services reduced its AbbVie (ABBV) stake by 3.7% in Q1 2026, selling an estimated $197K and leaving 23,152 shares worth $5.04M. The position accounts for 0.29% of the portfolio, ranked #81.

McKinley Carter Wealth Services first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.56M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • McKinley Carter Wealth Services held 23,152 shares of AbbVie worth $5.04M as of Q1 2026.
  • McKinley Carter Wealth Services sold 890 AbbVie shares in Q1 2026, an estimated $197K.
  • AbbVie made up 0.29% of McKinley Carter Wealth Services's portfolio in Q1 2026, its #81 holding.
  • McKinley Carter Wealth Services first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • McKinley Carter Wealth Services's AbbVie position peaked at $5.56M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on McKinley Carter Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.